France vs South Asia: Cause of death, by non-communicable diseases, ages 60+, male
France
79.5%
in 2021
South Asia
51.0%
in 2021
France rank
45th
South Asia rank
46th
Cause of death, by non-communicable diseases, ages 60+, male over time
- France
- South Asia
How they compare
France currently reports 79.5% against 51.0% in South Asia, a difference of 28.5%.
That makes France's figure about 1.6 times South Asia's.
Across all 6 years both countries report, France has been ahead every year.
France ranks 45th and South Asia ranks 46th of 185 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | South Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.0% | 65.9% | 23.0% | France |
| 2010s | 88.6% | 77.4% | 11.2% | France |
| 2020s | 78.2% | 61.6% | 16.6% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, France or South Asia?
- France, at 79.5% against 51.0% in South Asia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between France and South Asia?
- 28.5%, with France ahead.
- How many years of comparable data are there for France and South Asia?
- 6 years are reported by both, from 2000 to 2021.
- How do France and South Asia rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- France ranks 45th and South Asia ranks 46th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.